25 Aug 2017
Kate: I’m making a difference
Kate’s mother died of acute myloid leukaemia at the age of 34, leaving behind four young children. When Kate reached the same age, she took up running and began to raise money for our cause
My mum died after a short battle with acute myeloid leukaemia. She was 34 and left four children behind – I was eight years old.
I started running nearly three years ago, the year I turned 34. I started with 10k a month for a year, building up to half marathons last year.
I’ve always watched the London Marathon in awe, thinking I would love to do it but never thought it possible. I chose to run it for Leukaemia UK because I wanted to find a leukaemia charity that was relatively local, so that by raising money I would make a difference.
Kate completed the Great North Run and the Great South Run for Leukaemia UK in 2016, then the London Marathon and the Royal Parks Half Marathon in 2017. She raised more than £3,000 for Leukaemia UK – what an inspiration!
We are delighted that Kate has chosen to support us in memory of her mother and are so impressed with her dedication and determination. Thank you!
Read further inspiring fundraising stories, including Esther’s half marathon journey.
Read more stories from our community.
13 November 2023
This year’s Olive Boles Innovation Award winner announced
Dr Kevin Rattigan, University of Glasgow, has been selected as this year’s Olive Boles Innovation Award winner – an accolade given to one Leukaemia UK John Goldman Fellow each year….
4 August 2020
Our life-saving work must continue
Leukaemia and other blood cancers don’t stop for coronavirus (COVID-19) and our vital research and care must continue
11 August 2021
Dr Samanta Mariani recognised for her innovative research through Leukaemia UK John Goldman Fellowship and Olive Boles Innovation Award
We are delighted to announce the Leukaemia UK John Goldman Fellowship and Olive Boles Innovation Award has been awarded to Dr Samanta Mariani, in recognition of her innovative research that could contribute significantly to our understanding of leukaemia and other blood cancers.
11 March 2022
Inquiry highlights the impact of COVID-19 on blood cancer services
A new report has recently been published, following an inquiry by the All-Party Parliamentary Group (APPG) on Blood Cancer and the APPG on Stem Cell Transplantation and Advanced Cellular Therapies, on the impact of Covid-19 on blood cancer services in the UK.